Accessibility Menu
Health Advance logo

Health Advance(OTC) HADV

Market Cap$194.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-99%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Health Advance last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-25
Health Advance stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-08-18
1 month+0%USD 0.002026-07-24
3 month+0%USD 0.002026-05-22
Year to date-33.33%USD 0.002025-12-31
1 year+0%USD 0.002025-08-25
3 year-92.31%USD 0.002023-08-25
5 year-99.62%USD 0.052021-08-26
Since inception-98.67%USD 0.022012-09-13

Health Advance Financials at a Glance

Market Cap

$194.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$87.21K

EPS (TTM)

-$0.00

P/E Ratio

-2.00

Dividend

$0.00

Beta (Volatility)

0.04 (Low)

Price

$0.00

Volume

5,005,324

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

HADV News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Health Advance

Health Advance Inc. is a development-stage company focused on providing a wide range of home medical supplies across Canada and the United States. The company operates through its e-commerce platform, leadingmedicalproducts.com, catering to both healthcare professionals and individual consumers.

Products and Services
  • Assistive devices for daily living and mobility aids
  • Comprehensive wound care and diabetic management products
  • Home diagnostic kits and respiratory equipment
Growth Outlook
  • Plans to expand inventory to meet increasing demand for home medical supplies
  • Targeting healthcare professionals and medical distributors for broader market reach
  • Potential for growth in the e-commerce sector within the healthcare industry
Financial Highlights
  • Trailing twelve months (TTM) revenue of $0, indicating early-stage operations
  • Net income for the most recent quarter was -$50,308, reflecting ongoing investment in growth
  • Current ratio of 0.79 suggests a focus on managing short-term liabilities
Health Advance Inc. is positioned in the healthcare sector, specifically within the medical and pharmaceutical industry. The company aims to address the growing need for home medical supplies, which has become increasingly relevant in recent years. With a comprehensive product range, Health Advance Inc. is set to cater to a diverse customer base, including healthcare professionals and individual consumers. The growth outlook remains promising, as the company plans to expand its inventory and enhance its e-commerce capabilities. This strategic focus on online sales aligns with current market trends, where consumers increasingly prefer digital shopping experiences. Financially, the company is in a development phase, with no revenue reported in the trailing twelve months. However, the recent net income loss indicates significant investment in operational capabilities and market penetration. The current ratio suggests that while there are challenges, the company is managing its short-term liabilities effectively. Overall, Health Advance Inc. presents an intriguing opportunity for investors interested in the evolving healthcare landscape, particularly in the realm of home medical supplies.
AI Generated • Aug 8, 2026

Industry

Specialty Retail

Employees

2

CEO

Larry McLachlin

Headquarters

Las Vegas, NV 89103, US

HADV Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

55.38%

Return on Capital

-37.62%

Return on Assets

-17.29%

Earnings Yield

-50.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$194.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

974.14M

Volume

5.01M

Avg. Volume

496.91K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$65.41K

EBITDA

-$65.41K

Operating Cash Flow

-$56.19K

Capital Expenditure

$0.00

Free Cash Flow

-$56.19K

Cash & ST Invst.

$1.28K

Total Debt

$357.45K

Health Advance Performance Analysis

Health Advance annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31USD 0N/A
20242024-03-31USD 0N/A
20252025-03-31USD 0N/A
20262026-03-31USD 0N/A
Health Advance sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Q42026-03-31N/A
Health Advance annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31USD -0.0075.0%
20242024-03-31USD -0.00-78.6%
20252025-03-31USD -0.00-66.7%
20262026-03-31USD -0.000.0%
Health Advance sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Q42026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$194.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$64.93K

N/A

Employees

3

N/A

Net Income

-$10.92K

+0.0%

EBITDA

-$10.49K

-0.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$1.28K

+215.0%

Total Debt

$357.45K

+18.4%

Accounts Receivable

$36.23K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$277.52K

+9.2%

Short Term Debt

$79.93K

+66.9%

Return on Assets

-17.29%

N/A

Return on Invested Capital

-69.63%

N/A

Free Cash Flow

-$5.20K

+0.2%

Operating Cash Flow

-$5.21K

-0.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMMBImmunotech Laboratories, Inc.
$0.00+0.00%
DECNDecision Diagnostics Corp.
$0.00+0.00%
SPPHSpencer Pharmaceutical Inc.
$0.00+0.00%
NNBPNanobac Pharmaceuticals, Incorporated
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CRECre8 Enterprise
$6.21+1.42%
BITOProShares Trust - ProShares Bitcoin ETF
$10.56-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76-0.04%
NVDANvidia
$210.27-0.01%

Questions About HADV

What is the current price of Health Advance?

Health Advance is trading at $0.00 per share.

What is the 52-week range for Health Advance?

Over the past 52 weeks, Health Advance has traded between $0.00 and $0.00.

How much debt does Health Advance have?

As of the most recent reporting period, Health Advance reported total debt of $351.66K.

How much cash does Health Advance have on hand?

Health Advance reported $1.30K in cash and cash equivalents in its most recent financial results.

What is Health Advance’s dividend yield?

Health Advance does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.